Unknown

Dataset Information

Non-Small-Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy.


ABSTRACT: As the leading cause of cancer death worldwide, lung cancer continues to impose a major burden on healthcare systems and cause significant challenges for clinicians and patients. Most patients present with advanced disease at the time of diagnosis and have a poor prognosis, with the vast majority surviving less than 5 years. Although new therapies have been introduced in recent years that target molecular disease drivers present in a subset of patients, there is a significant need for treatments able to improve response and extend survival while minimizing effects on quality of life. Recent evidence of clinical efficacy for immunotherapeutic approaches for lung cancer suggests that they will become the next major therapeutic advance for this disease. Non-small-cell lung cancer, which accou

SUBMITTER: Carbone DP 

PROVIDER: S-EPMC4618296 | biostudies-literature | 2015 Jul

REPOSITORIES: biostudies-literature